WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009067639) VARIANTS OF C-TYPE NATRIURETIC PEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/067639    International Application No.:    PCT/US2008/084270
Publication Date: 28.05.2009 International Filing Date: 21.11.2008
IPC:
C07K 14/58 (2006.01), A61K 38/22 (2006.01)
Applicants: BIOMARIN PHARMACEUTICAL INC. [US/US]; 105 Digital Drive, Novato, CA 94949 (US) (For All Designated States Except US).
WENDT, Dan, J. [US/US]; (US) (For US Only).
AOYAGI-SCHARBER, Mika [JP/US]; (US) (For US Only).
BELL, Sean [US/US]; (US) (For US Only).
WEI, Dong [US/US]; (US) (For US Only).
KAKKIS, Emil, D. [US/US]; (US) (For US Only).
BLIESATH, Joshua, R. [US/US]; (US) (For US Only)
Inventors: WENDT, Dan, J.; (US).
AOYAGI-SCHARBER, Mika; (US).
BELL, Sean; (US).
WEI, Dong; (US).
KAKKIS, Emil, D.; (US).
BLIESATH, Joshua, R.; (US)
Agent: NEVILLE, Katherine, L.; Marshall, Gerstein & Borun Llp, 233 S. Waker Drive, Suite 6300, Sears Tower, Chicago, IL 60606-6357 (US)
Priority Data:
60/989,497 21.11.2007 US
61/061,488 13.06.2008 US
Title (EN) VARIANTS OF C-TYPE NATRIURETIC PEPTIDE
(FR) VARIANTES DE PEPTIDE NATRIURÉTIQUE DE TYPE C
Abstract: front page image
(EN)The present invention provides variants of C-type natriuretic peptide (CNP) comprising one or more deletions; additions of and/or substitutions with natural amino acids, unnatural amino acids and/or peptidomimetics (including peptide bond isosteres); amino acid extensions; and/or other chemical moieties such as, e.g., poly(ethylene glycol) and hydrophobic acids. The CNP variants are useful as therapeutic agents for the treatment of diseases responsive to CNP, including but not limited to bone-related disorders such as, e.g., skeletal dysplasias and achondroplasia, and vascular smooth muscle disorders such as, e.g., restenosis and arteriosclerosis.
(FR)L'invention concerne des variantes de peptide natriurétique de type C (CNP) comprenant une ou plusieurs délétions, additions et/ou substitutions avec des acides aminés naturels, des acides aminés non naturels et/ou des substances peptidomimétiques (y compris des isostères de liaison peptidique); des extensions d'acides aminés; et/ou d'autres fractions chimiques telles que, par exemple, le poly(éthylène glycol) et les acides hydrophobes. Les variantes de CNP sont utiles comme agents thérapeutiques pour le traitement de maladies réactives au CNP, y compris, sans s'y limiter, les troubles liés aux os tels que, par exemple, les dysplasies squelettiques et l'achondroplasie, et les troubles des muscles lisses vasculaires tels que, par exemple, la resténose et l'artériosclérose.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)